SLC7A5 and small cell lung carcinoma: In KRAS-mutant colorectal cancer cells, SLC7A5 maintained intracellular amino acid level and activated mTOR pathway, which finally supported cell proliferation [23]; in small cell lung cancer, increased SLC7A5 promoted cell growth [24].